Abstract
Purpose
We developed a method of standardizing the heart-to-mediastinal ratio in 123I-labeled meta-iodobenzylguanidine (MIBG) images using a conversion coefficient derived from a dedicated phantom. This study aimed to create a machine-learning (ML) model to estimate conversion coefficients without using a phantom.
Methods
210 Monte Carlo (MC) simulations of 123I-MIBG images to obtain conversion coefficients using collimators that differed in terms of hole diameter, septal thickness, and length. Simulated conversion coefficients and collimator parameters were prepared as training datasets, then a gradient-boosting ML was trained to estimate conversion coefficients from collimator parameters. Conversion coefficients derived by ML were compared with those that were MC simulated and experimentally derived from 613 phantom images.
Results
Conversion coefficients were superior when estimated by ML compared with the classical multiple linear regression model (root mean square deviations: 0.021 and 0.059, respectively). The experimental, MC simulated, and ML-estimated conversion coefficients agreed, being, respectively, 0.54, 0.55, and 0.55 for the low-; 0.74, 0.70, and 0.72 for the low-middle; and 0.88, 0.88, and 0.88 for the medium-energy collimators.
Conclusions
The ML model estimated conversion coefficients without the need for phantom experiments. This means that conversion coefficients were comparable when estimated based on collimator parameters and on experiments.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Background
Cardiac scintigraphy with the noradrenaline analog 123I-labeled meta-iodobenzylguanidine (MIBG) is now an established means of evaluating heart failure1,2,3,4,5,6 and neurodegenerative diseases.7,8,9,10,11,12,13 The heart-to-mediastinum ratio (HMR) is calculated as the average count ratio of 123I-MIBG-derived activity in a cardiac region of interest (ROI) and that in the mediastinal ROI,14,15 can quantify cardiac sympathetic nerve activity in 123I-MIBG images.
The HMR considerably varies due to differences in the characteristics of gamma cameras and low-energy (LE), low-middle-energy (LME), and middle-energy (ME) collimators, that are used for 123I-MIBG imaging. High-energy photons emitted by 123I radionuclides can easily penetrate the thin septa of collimators. To overcome HMR variations due to collimator characteristics in gamma camera imaging systems, we developed an acrylic chest phantom that mimics the 123I-MIBG distribution in organs on planar images, then calibrated the HMR based on conversion coefficients.16,17,18,19,20,21,22 This method allowed for HMR values derived from various collimators and gamma camera combinations to be adjusted and unified to a standard gamma camera with a standard collimator. The method has been validated by phantom imaging at several medical centres in Europe and Japan.17,23,24,25,26 We then fit the conversion coefficients to the characteristics of collimators in 123I-MIBG imaging based on those results. However, the combinations of commercially available collimators and gamma cameras are numerous in current camera systems and as new cameras or collimators become available, further phantom imaging will be needed.
We, therefore, propose a new standardization method that does not require phantom experiments. We aimed to simulate images of 123I-MIBG phantoms using the Monte Carlo (MC) method with various collimator parameters, to calculate conversion coefficients from simulated phantom images, and to generate a machine learning (ML) model that could estimate conversion coefficients from collimator parameters.
Methods
Calibration phantom for planar 123 I-MIBG imaging
A flat, polymethyl methacrylate phantom (width × depth × height: 380 × 380 × 50 mm3, Taisei Medical, Co. Ltd, Osaka, Japan) was developed to simulate 123I-MIBG distribution in the heart, mediastinum, liver, lungs, and thyroid gland (Figure 1a). A digital version of the phantom was created from an X-ray CT scan with different segmented compartments (Figure 1b) to obtain a three-layer map of activity. Background activity was represented in the basal layer. Cardiac, pulmonary, hepatic, and thyroid activities were represented in layers 1 and 2. Details of the phantom design have been published elsewhere.16,22
Monte Carlo simulation for 123 I-MIBG imaging
We simulated 123I-MIBG planar imaging using the Simulated Imaging Nuclear Detectors (SIMIND) MC code.27 Since many simulation parameters for the gamma cameras were not available, we applied a standard gamma camera in all MC simulations that had a crystal thickness, width, and length, 9.5 (3/8 inch), 269.5, and 250 mm, respectively; backscatter material and cover thickness, 76 and 1.0 mm, respectively; energy resolution, 9.8% (FWHM at 140 keV); intrinsic resolution, 3.8 mm; energy window,159 keV ± 10.0%; matrix and pixel sizes, 256 × 256 and 2.21 mm, respectively. All MC simulations generated 123I-MIBG planar images using a total of 1.78 × 109 photons.
Simulation 1: Eighteen collimators were simulated for the following gamma camera systems: Infinia, Millennium MG, and Millennium VG (GE Healthcare, Waukesha, WI, USA); PRISM-AXIS and IRIX (Picker Corporation, Cleveland, OH, USA); Brightview (Philips Medical Systems, Milpitas, CA, USA); Symbia and E.CAM (Siemens Healthineers, Erlangen, Germany). Table 1 shows details of the collimator parameters. All MC simulations were repeated three times per collimator.
Simulation 2: We simulated 283 collimators with hole diameters of 1.0, 1.25, 1.50, 1.75, 2.0, 2.5, 3.0, and 3.5 mm; septal thickness of 0.15, 0.2, 0.25, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1.2, and 1.5 mm; and lengths of 20, 25, 30, 35, 40, 45, 50, 55, and 60 mm.
Simulation 3: Three collimators were simulated for the Discovery NM series (GE Healthcare) with respective to hole diameters, septal thicknesses, and collimator lengths of 1.5, 0.2, and 35.0 mm, for the low-energy high-resolution (LEHR) type; 2.5, 0.4, and 40.0 mm for the extended low-energy general-purpose (ELEGP) type; 3.0, 1.05, and 58.0 mm for the medium-energy general-purpose (MEGP) type. All MC simulations were repeated five times per collimator.
123 I-MIBG phantom image database for validating results of MC simulation
We generated a multicenter database of 123I-MIBG experimental phantom images accumulated in Japan over a period of 15 years.16 Two image datasets were selected from the database to validate the results of MC simulations 1 and 3 as follows.
Validation dataset for MC simulation 1: Seven gamma cameras and collimators were selected from the database along with 153, 33, 40, 36, 73, 39, and 60 phantom images acquired using Infinia, Millennium MG, Millennium VG, BrightView, AXIS/IRIX, Symbia, and E.CAM systems, respectively.
Validation dataset for MC simulation 3: We selected phantom images from the database using the gamma camera of Discovery NM 630, 640, 670, 830, and 850 systems (GE Healthcare). Among these, 26, 107, and 46 were acquired using LEHR, ELEGP, and MEGP collimators.
Planar images in both datasets were acquired from a phantom containing 111 MBq of 123I-MIBG. Planar imaging proceeded with 256 × 256 or 512 × 512 matrices. The photopeak window of 123I was centered at 159 keV with a 20% energy window. The maximum, minimum, and median acquisition durations were 600, 180, and 300 s, respectively.
Monte Carlo simulation using standard and original detector conditions
We confirmed the conversion coefficients derived from standard detector conditions with those from original detector conditions in six commercially available gamma cameras. Table 2 shows the crystal thickness, intrinsic resolution, and energy resolution in the original detector conditions. The other detector parameters for backscatter material and cover thickness were set as 76 mm and 1.0 mm, respectively. Regarding the imaging condition, the energy window, matrix size, and pixel sizes were set as 159 keV ± 10.0%, 256 × 256, and 2.21 mm, respectively. All MC simulations generated 123I-MIBG planar images using a total of 1.78 × 109 photons. All MC simulations were repeated five times in the standard and original detector conditions.
Image analysis
A calibration factor was calculated from two HMR values derived from anterior (HMRAnt) and posterior (HMRPost) planar 123I-MIBG phantom images as a conversion coefficient:
where 2.6 and 3.5 are the respective designated HMRs in the anterior and posterior views of the calibration phantom.22 We developed ROI setting software for phantom image analysis. Standardized circular and rectangular ROIs were automatically delineated on the heart and mediastinum. These ROI sizes and positioning were determined based on the smartMIBG software program.28
Machine learning (ML) model
We estimated conversion coefficients using an ML algorithm for regression analysis. We applied a gradient-boosting regression algorithm using scikit-learn29 to estimate conversion coefficients by building seven models with hole diameter, septal thickness, and collimator length. The conversion coefficients and related collimator parameters were randomly divided into training and validation datasets in a ratio of 3:2. We performed cross-validation for the machine learning prediction models using a fourfold model. The optimal ranges of hyperparameter values for the ML algorithm of 0.01-0.5 for the learning rate, 1-100 for the number of estimators, and 1-8 for the maximum depth of the individual regression estimators were determined using a grid search. Default values were applied to the remaining hyperparameters. Feature importances of the hole diameter, septal thickness, and collimator length were evaluated using the permutation feature importance provided by the scikit-learn.30
Conventional multiple linear regression model
We estimated conversion coefficients using a conventional multiple linear regression model. Collimator parameters of the hole diameter, septal thickness, and collimator length were used to build the model. The conversion coefficients and related collimator parameters were randomly divided into training and validation datasets in a ratio of 3:2. The software machine learning library, scikit-learn,29 was used.
Statistical analysis
All continuous parametric variables are expressed as means ± standard deviation (SD), and non-parametric data are presented as medians. Differences in continuous variables were analyzed using Student t-tests and Wilcoxon signed-rank tests. Multiple comparisons of continuous variables were assessed using Tukey–Kramer tests. Differences in paired continuous data were analyzed using paired t-tests. A root mean square error (RMSE) is used to measure the error of a model in predicting conversion coefficients. All statistical tests were two-tailed, and values with p < 0.05 were considered significant. All data were statistically analyzed using JMP version 11.2.1 (SAS Institute Inc., Cary, NC, USA).
Results
The quality of the simulated and experimental phantom images was equivalent in terms of LEHR and MEGP collimator conditions (Figure 1c). A comparison of the average of simulation and experimental conversion coefficients among seven camera systems revealed that higher mean values were in the experimental than the simulated images for 10 collimators (Figure 2a). The regression line of averaged experimental conversion coefficients (Y) as a function of simulated values (X) was Y = 1.27X-0.15 (R2 = 0.96; Figure 2b). The simulated conversion coefficients were compensated using this equation in subsequent analyses. Hole diameter and septal thickness closely correlated with conversion coefficients (Figure 2c).
When the original detector parameters: the intrinsic resolutions were 3.3-3.8 mm for the 3/8-inch crystal and 4.5 mm for the 5/8-inch crystal; and the energy resolution were 9.5-9.9%, were used in MC simulation, the conversion coefficients derived from the original and standard detector conditions were comparable in LE and ME collimators (Table 2). The influence of the differences between original and standard detector parameters on conversion coefficients was small. A lookup table of conversion coefficients is available in Table 2. The conversion coefficients of LE collimators were within the ranges of 0.49-0.56 for the 3/8-inch crystal and of 0.59-0.61 for the 5/8-inch crystal. The conversion coefficients of ME collimators were 0.85-0.89 and 0.88-0.91 in the 3/8-inch and 5/8-inch crystals, respectively.
The HMR and related conversion coefficients were calculated using 283 collimator parameters (Supplementary Figure 1). We excluded 73 from the following analyses due to high septal penetration (> 1.0%). Conversion coefficients calculated from the remaining 210 collimator parameters were all within the range of 0.44-0.94 (Figure 3a). Although correlations between conversion coefficients and collimator parameters were positive, the range of R2 values was 0.2-0.75 (Figure 3b). Agreements between actual and predicted conversion coefficients were evaluated using scatter plots (Figure 3c). Analysis of the seven ML models using combinations of collimator diameter, septal thickness, and collimator length, revealed that the smallest RMSE was 0.0207 when these collimator parameters were incorporated (Figure 3d). Tuned hyperparameters for this ML condition were as follows: learning rate, 0.33; the number of estimators, 25; maximum depth of individual regression estimators, two. Conventional multiple linear regression analysis using the three parameters provided an RMSE of 0.0588. The higher score of feature importance was 1.5 ± 0.15 for septal thickness and the lower scores were 0.057 ± 0.0088 for hole diameter and 0.0080 ± 0.0017 for collimator length.
The experimentally derived, MC simulation, and ML-estimated conversion coefficients in 123I-MIBG phantom images (Figure 4a) were, respectively, 0.54 ± 0.023, 0.55 ± 0.0082, and 0.55 for LEHR, 0.74 ± 0.025, 0.70 ± 0.0066, and 0.72 for ELEGP, and 0.88 ± 0.030, 0.88 ± 0.014, and 0.88 for MEGP (Figure 4b).
Discussion
The main findings of the present study were that conversion coefficients were slightly underestimated when simulated compared with experimental results, and were corrected with the regression line of experimental conversion coefficients on simulated results. Simulated conversion coefficients closely were correlated with collimator parameters. The ML models revealed that conversion coefficients could be precisely estimated from collimator parameters. The experimentally derived and ML-estimated conversion coefficients closely agreed in the validation study.
We have promoted a phantom-based methodology to standardize the HMR in 123I-MIBG imaging. Many cardiological and neurological studies have determined HMRs without standardization1,2,3,7,10,31,32 and this has led to wide variations in clinical normal values and HMR thresholds. Clinical criteria to determine the prognosis of heart failure would change by these HMR values as the optimal threshold of the HMR for diagnosing neurological disorders would be influenced by non-standardized conditions. Moreover, regardless of whether diagnostic models were generated using statistical or ML approaches based on non-standardized HMRs, variations in these values cannot be excluded from estimations. Therefore, a standard HMR should be mandatory in 123I-MIBG imaging.
The simulated conversion coefficients were underestimated compared with those determined under actual MEGP collimator conditions. Assessment of the penetration fraction of the ME collimator in published simulation studies revealed that Rault et al. found a 3% penetration fraction using a point source.33 Moreover, Konik et al. found ~ 4% penetration fraction using a point source and the 4D extended cardiac-torso (XCAT) digital phantom.34 The geometry and tracking 4 (GEANT4) application for tomographic emission (GATE) package35 was used in these studies. The mean penetration fraction was 7.2% in our simulation. Slight differences in the penetration fraction could have influenced the simulated conversion coefficients.
Numerous parameters for gamma cameras and collimators should be fixed to reproduce actual phantom experiments in MC simulations. When the densities of the collimator material were fixed at 11.34 (Pb,100%); 11.25 (Pb 98%, Sb2%); 11.20 (Pb 97%, Sb 3%); 11.15 (Pb 96%, Sb 4%); and 11.06 (Pb 94%, Sb 6%) g/cm3, the conversion coefficients changed from 0.80 to 0.83 even with the ME collimator. The contribution of high-energy photon backscatter from the photomultiplier tube was also fixed. When the backscatter material thickness was 3.8, 7.6 (default), and 11.4 cm, the conversion coefficients slightly changed from 0.79 to 0.81. In summary, the effects of collimator material densities and backscatter material thickness on the conversion factor were limited under the conditions of MC simulation.
Some factors influence the conversion coefficients except collimators and cameras. We exhibited that the primary energy window setting for the image acquisition condition affected the conversion coefficients.16 The conversion coefficients showed higher values when images were acquired with the energy windows of 159 keV ± 7.5% than 159 keV ± 10%. However, the energy window of 159 keV ± 7.5% was not popular as 123I-MIBG acquisition condition. Conversely, equivalent conversion coefficients were observed in imaging matrices of 256 and 512.16 When we evaluated the variations of conversion coefficients in two dual-head gamma camera positioning: parallel-mode and L-mode configurations, the conversion coefficients did not differ significantly between the two configurations. In addition, even when the distances between phantom and the opposite gamma camera that did not acquire planar data were changed, the conversion coefficients were stable at any distance. The effects of the gamma camera configurations on the variation of conversion coefficients may be therefore negligible.
The ML model provided reasonable conversion coefficients using only the specifications of collimator designs. Since the collimator parameters were nonlinearly associated with conversion coefficients, ML would be suitable for these data compared with simple statistical and multiple linear regression models. Considering the selection of parameters in collimator design, septal thickness was pivotal to estimate conversion coefficients. Moreover, the combination of septal thickness, hole diameter, and collimator length generated excellent estimates of conversion coefficients.
The interpretation of the ML model is important for applying the ML to simulation data. We have preliminary compared gradient-boosting regression with kNN, linear regression, and support vector machine using the orange data mining toolbox in python36 (Supplementary Figure 2). A total of 210 conversion coefficients with three collimator parameters were used as test data. A cross-validation using a fivefold model was applied to calculate RMSE values. The gradient-boosting regression showed the smallest RMSE of 0.016. The gradient-boosting regression model was suitable for our dataset.
Although MC simulation can directly estimate conversion coefficients based on collimator designs, MC simulations of 123I-MIBG phantom imaging are very laborious. Consequently, we estimated conversion coefficients using the ML algorithm instead of MC simulation. However, we suggest that actual phantom experiences at each institution are still needed to obtain conversion coefficients, particularly as new gamma cameras and collimators are developed. The vendors of the cameras may sometimes update and modify collimator designs. When the collimators will be modified or newly created, we need to perform MIBG phantom experiments to calculate conversion coefficients fitted for the new specifications. Our results are, however, utilized for Anger-type gamma cameras with lead collimators. When a new collimator is available with its specifications, our ML model might be able to estimate appropriate conversion coefficients for the modified collimator even without phantom experiments. In addition, the applicability of current cadmium-zinc-telluride detectors awaits validation. When calculated conversion coefficients are out of range in institutional phantom images, the ML model can provide a standard conversion coefficient based on combinations of collimator and gamma camera parameters.
Our study has several limitations. MC simulations cannot reproduce all the physical phenomena involved in 123I-MIBG imaging. Further, MC simulations with numerous collimator parameters are needed to improve the performance of the ML model. The clinical impact on patient diagnosis was not evaluated using the ML-estimated conversion coefficients in this study. We evaluated the clinical impact on patient diagnosis using conversion coefficients derived from real phantom images in our previous study.16 The net reclassification improvement in 21 normal subjects and 12 patients with heart failure showed 14.3% when the HMR values were corrected using the conversion coefficients. Therefore, if we can assume that the conversion coefficients by the simulation and the phantom experiment were equivalent, comparable clinical impacts would be provided by the simulations and experiments.
New knowledge gained
The MC simulations were very helpful for estimating the results of basic phantom experiments in 123I-MIBG images. These results could serve as training and validation materials for the ML algorithm. In addition to actual 123I-MIBG phantom experiments, combined ML and MC simulations would aid HMR standardization.
Conclusions
We aimed to estimate conversion coefficients for the HMR ratio in 123I-MIBG images using ML models. We found that the ML model could reasonably estimate conversion coefficients based on the fundamental collimator parameters of septal thickness, hole length, and diameter. Conversion coefficients in the validation study were equivalent between the ML model and the experimental results. Our proposed methodology will contribute to the HMR standardization of 123I-MIBG scintigraphy.
Abbreviations
- 123I-MIBG:
-
123I-labeled meta-iodobenzylguanidine
- HMR:
-
Heart-to-mediastinum count ratio
- LE:
-
Low energy
- MC:
-
Monte Carlo
- ME:
-
Medium energy
- ML:
-
Machine learning
References
Jacobson AF, Senior R, Cerqueira MD, Wong ND, Thomas GS, Lopez VA. Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study. J Am Coll Cardiol 2010;55:2212‐21.
Nakata T, Nakajima K, Yamashina S, Yamada T, Momose M, Kasama S, et al. A pooled analysis of multicenter cohort studies of (123)I-mIBG imaging of sympathetic innervation for assessment of long-term prognosis in heart failure. JACC Cardiovasc Imaging 2013;6:772‐84.
Verschure DO, Veltman CE, Manrique A, Somsen GA, Koutelou M, Katsikis A, et al. For what endpoint does myocardial 123I-MIBG scintigraphy have the greatest prognostic value in patients with chronic heart failure? Results of a pooled individual patient data meta-analysis. Eur Heart J Cardiovasc Imaging 2014;15:996‐1003.
Travin MI, Matsunari I, Thomas GS, Nakajima K, Yoshinaga K. How do we establish cardiac sympathetic nervous system imaging with 123I-<I>m</I>IBG in clinical practice? Perspectives and lessons from Japan and the US. Ann Nucl Cardiol 2019;5:5‐20.
Schofer J, Spielmann R, Schuchert A, Weber K, Schluter M. Iodine-123 meta-iodobenzylguanidine scintigraphy: a noninvasive method to demonstrate myocardial adrenergic nervous system disintegrity in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 1988;12:1252‐8.
Wieland DM, Brown LE, Rogers WL, Worthington KC, Wu JL, Clinthorne NH, et al. Myocardial imaging with a radioiodinated norepinephrine storage analog. J Nucl Med 1981;22:22‐31.
Orimo S, Suzuki M, Inaba A, Mizusawa H. 123I-MIBG myocardial scintigraphy for differentiating Parkinson’s disease from other neurodegenerative parkinsonism: A systematic review and meta-analysis. Parkinsonism Relat Disord 2012;18:494‐500.
Orimo S, Ozawa E, Nakade S, Sugimoto T, Mizusawa H. (123)I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson’s disease. J Neurol Neurosurg Psychiatry 1999;67:189‐94.
Treglia G, Cason E, Stefanelli A, Cocciolillo F, Di Giuda D, Fagioli G, et al. MIBG scintigraphy in differential diagnosis of Parkinsonism: A meta-analysis. Clin Auton Res Soc 2012;22:43‐55.
Yoshita M, Taki J, Yokoyama K, Noguchi-Shinohara M, Matsumoto Y, Nakajima K, et al. Value of 123I-MIBG radioactivity in the differential diagnosis of DLB from AD. Neurology 2006;66:1850‐4.
Yoshita M, Arai H, Arai H, Arai T, Asada T, Fujishiro H, et al. Diagnostic accuracy of 123I-meta-iodobenzylguanidine myocardial scintigraphy in dementia with Lewy bodies: A multicenter study. PLoS ONE 2015;10:e0120540.
Komatsu J, Samuraki M, Nakajima K, Arai H, Arai H, Arai T, et al. (123)I-MIBG myocardial scintigraphy for the diagnosis of DLB: A multicentre 3-year follow-up study. J Neurol Neurosurg Psychiatry 2018;89:1167‐73.
Yamada M, Komatsu J, Nakamura K, Sakai K, Samuraki-Yokohama M, Nakajima K, et al. Diagnostic criteria for dementia with Lewy bodies: Updates and future directions. J Mov Disord 2020;13:1‐10.
Merlet P, Valette H, Dubois-Rande JL, Moyse D, Duboc D, Dove P, et al. Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure. J Nucl Med 1992;33:471‐7.
Veltman CE, Boogers MJ, Meinardi JE, Al Younis I, Dibbets-Schneider P, Van der Wall EE, et al. Reproducibility of planar (123)I-meta-iodobenzylguanidine (MIBG) myocardial scintigraphy in patients with heart failure. Eur J Nucl Med Mol Imaging 2012;39:1599‐608.
Okuda K, Nakajima K, Kitamura C, Kirihara Y, Hashimoto M, Kinuya S. Calibrated scintigraphic imaging procedures improve quantitative assessment of the cardiac sympathetic nerve activity. Sci Rep 2020;10:21834.
Nakajima K, Verschure DO, Okuda K, Verberne HJ. Standardization of (123)I-meta-iodobenzylguanidine myocardial sympathetic activity imaging: phantom calibration and clinical applications. Clin Transl Imaging 2017;5:255‐63.
Nakajima K, Okuda K, Yokoyama K, Yoneyama T, Tsuji S, Oda H, et al. Cross calibration of (123)I-meta-iodobenzylguanidine heart-to-mediastinum ratio with D-SPECT planogram and Anger camera. Ann Nucl Med 2017;31:605‐15.
Nakajima K, Okuda K, Matsuo S, Agostini D. The time has come to standardize (123)I-MIBG heart-to-mediastinum ratios including planar and SPECT methods. Eur J Nucl Med Mol Imaging 2016;43:386‐8.
Nakajima K, Okuda K, Yoshimura M, Matsuo S, Wakabayashi H, Imanishi Y, et al. Multicenter cross-calibration of I-123 metaiodobenzylguanidine heart-to-mediastinum ratios to overcome camera-collimator variations. J Nucl Cardiol 2014;21:970‐8.
Nakajima K, Okuda K, Matsuo S, Yoshita M, Taki J, Yamada M, et al. Standardization of metaiodobenzylguanidine heart to mediastinum ratio using a calibration phantom: effects of correction on normal databases and a multicentre study. Eur J Nucl Med Mol Imaging 2012;39:113‐9.
Nakajima K, Matsubara K, Ishikawa T, Motomura N, Maeda R, Akhter N, et al. Correction of iodine-123-labeled meta-iodobenzylguanidine uptake with multi-window methods for standardization of the heart-to-mediastinum ratio. J Nucl Cardiol 2007;14:843‐51.
Nakajima K, Okuda K, Verberne HJ. Phase dyssynchrony and (123)I-meta-iodobenzylguanidine innervation imaging towards standardization. J Nucl Cardiol 2019;26:519‐23.
Roberts G, Lloyd JJ, Kane JPM, Durcan R, Lawley S, Howe K, et al. Cardiac (123)I-MIBG normal uptake values are population-specific: Results from a cohort of controls over 60 years of age. J Nucl Cardiol 2021;28:1692‐701.
Verschure DO, Poel E, Nakajima K, Okuda K, van Eck-Smit BLF, Somsen GA, et al. A European myocardial (123)I-mIBG cross-calibration phantom study. J Nucl Cardiol 2018;25:1191‐7.
Nakajima K, Scholte A, Nakata T, Dimitriu-Leen AC, Chikamori T, Vitola JV, et al. Cardiac sympathetic nervous system imaging with (123)I-meta-iodobenzylguanidine: Perspectives from Japan and Europe. J Nucl Cardiol 2017;24:952‐60.
Ljungberg M, Strand SE. A Monte Carlo program for the simulation of scintillation camera characteristics. Comput Methods Programs Biomed 1989;29:257‐72.
Okuda K, Nakajima K, Hosoya T, Ishikawa T, Konishi T, Matsubara K, et al. Semi-automated algorithm for calculating heart-to-mediastinum ratio in cardiac Iodine-123 MIBG imaging. J Nucl Cardiol 2011;18:82‐9.
Pedregosa F, Varoquaux G, Gramfort A, Michel V, Thirion B, Grisel O, et al. Scikit-learn: Machine learning in Python. J Mach Learn Res 2011;12:2825‐30.
Altmann A, Tolosi L, Sander O, Lengauer T. Permutation importance: A corrected feature importance measure. Bioinformatics 2010;26:1340‐7.
Agostini D, Verberne HJ, Burchert W, Knuuti J, Povinec P, Sambuceti G, et al. I-123-mIBG myocardial imaging for assessment of risk for a major cardiac event in heart failure patients: insights from a retrospective European multicenter study. Eur J Nucl Med Mol Imaging 2008;35:535‐46.
Nakajima K. Normal values for nuclear cardiology: Japanese databases for myocardial perfusion, fatty acid and sympathetic imaging and left ventricular function. Ann Nucl Med 2010;24:125‐35.
Rault E, Vandenberghe S, Van Holen R, De Beenhouwer J, Staelens S, Lemahieu I. Comparison of image quality of different iodine isotopes (I-123, I-124, and I-131). Cancer Biother Radiopharm 2007;22:423‐30.
Konik A, Auer B, De Beenhouwer J, Kalluri K, Zeraatkar N, Furenlid LR, et al. Primary, scatter, and penetration characterizations of parallel-hole and pinhole collimators for I-123 SPECT. Phys Med Biol 2019;64:245001.
Sarrut D, Bala M, Bardies M, Bert J, Chauvin M, Chatzipapas K et al. Advanced Monte Carlo simulations of emission tomography imaging systems with GATE. Phys Med Biol 2021;66.
Demšar J, Curk T, Erjavec A, Gorup Č, Hočevar T, Milutinovič M, et al. Orange: data mining toolbox in Python. J Mach Learn Res 2013;14:2349‐53.
Acknowledgements
We thank the physicians and technologists who acquired phantom images to create the multicenter 123I-MIBG phantom database. The authors appreciate the editorial assistance of Norma Foster (English Express, North Vancouver, Canada).
Disclosures
K. Nakajima and K. Okuda collaborate with PDRadiopharma Inc., Tokyo, Japan, and K. Nakajima belongs to an endowed department partly funded by PDRadiopharma Inc. C. Kitamura, T. Hosoya, and Y. Kirihara are employees of PDRadiopharma Inc., Tokyo, Japan. M. Ljungberg and M. Hashimoto have no conflicts of interest. This study was supported in part by JSPS Grant-in-Aid for Early-Career Scientists (PI: K. Okuda, No. 18K15649) and JSPS Grants-in-Aid for Scientific Research (C) (PI: K. Nakajima, No. 20K07990); and Adaptable and Seamless Technology transfer Program through Target-driven R&D (A-STEP) from Japan Science and Technology Agency (JST) Grant Number JPMJTM20N8.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Okuda, K., Nakajima, K., Kitamura, C. et al. Machine learning-based prediction of conversion coefficients for I-123 metaiodobenzylguanidine heart-to-mediastinum ratio. J. Nucl. Cardiol. 30, 1630–1641 (2023). https://doi.org/10.1007/s12350-023-03198-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12350-023-03198-3